<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><copyright>Copyright 2010 Medical News Today</copyright><description>Latest Health News and Medical News posted throughout the day, every day.</description><link>http://www.medicalnewstoday.com/sections/cholesterol/</link><title>Cholesterol News From Medical News Today</title><webMaster>admin&#064;medicalnewstoday.com  (MNT Admin)</webMaster><managingEditor>editors&#064;medicalnewstoday.com  (MNT Editors)</managingEditor><language>en-us</language>
<item><title>Mizzou Scientist Creates A Chicken Substitute, Providing A Low&#45;Cost, Tasty Way To Add Soy To The Diet</title><pubDate>Fri, 05 Feb 2010 05:00:00 PST</pubDate><link>http://mnt.to/f/3xhR</link><guid>http://mnt.to/f/3xhR</guid><description>Sure, some delicacies might taste just like chicken, but they usually feel and look much different. Soy meat alternatives, such as the soy burger, have become more popular recently, with increased sales of eight percent from 2007 to 2008. Now, scientists at the University of Missouri have created a soy substitute for chicken that is much like the real thing...</description><category domain="http://www.medicalnewstoday.com/sections/nutrition-agriculture/">Nutrition / Diet</category></item>
<item><title>In Light Of Research About Teens' Heart Disease Risk, Lifestyle Changes Critical</title><pubDate>Thu, 04 Feb 2010 00:00:00 PST</pubDate><link>http://mnt.to/f/3x9N</link><guid>http://mnt.to/f/3x9N</guid><description>Pamphlets detailing the warning signs associated with heart disease may soon end up in an unexpected location: your child's pediatrician's office. According to new research from the Centers for Disease Control and Prevention (CDC), one in five American teens has at least one risk factor for developing heart disease in adulthood...</description><category domain="http://www.medicalnewstoday.com/sections/heart-disease/">Heart Disease</category></item>
<item><title>Cholesterol's Link To Heart Disease Gets Clearer &#45; And More Complicated</title><pubDate>Wed, 03 Feb 2010 04:00:00 PST</pubDate><link>http://mnt.to/f/3x8F</link><guid>http://mnt.to/f/3x8F</guid><description>By considering molecular&#45;level events on a broader scale, researchers now have a clearer, if more complicated, picture of how one class of immune cells goes wrong when loaded with cholesterol...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Siemens Introduces Cholesterol To The ADVIA Chemistry Concentrated Reagents Portfolio</title><pubDate>Fri, 29 Jan 2010 14:00:00 PST</pubDate><link>http://mnt.to/f/3wYD</link><guid>http://mnt.to/f/3wYD</guid><description>Siemens Healthcare Diagnostics has introduced concentrated Cholesterol, the 15th ADVIA&#174; Chemistry reagent in concentrated format. ADVIA Chemistry concentrated reagents offer up to 3060 tests per wedge, whilst still giving identical results to the conventional ADVIA non&#45;concentrated reagents...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Pomegranate Extract Stimulates Uterine Contractions</title><pubDate>Thu, 28 Jan 2010 04:00:00 PST</pubDate><link>http://mnt.to/f/3wSD</link><guid>http://mnt.to/f/3wSD</guid><description>The team identified beta&#45;sitosterol &#45; a steroid that can inhibit the absorption of cholesterol in the intestine &#45; as the main constituent of pomegranate seed extract. The research suggests that pomegranate extract could be used as a natural stimulant to encourage the uterus to contract during labour...</description><category domain="http://www.medicalnewstoday.com/sections/pregnancy/">Pregnancy / Obstetrics</category></item>
<item><title>Even Younger People Should Consider Cholesterol Screening</title><pubDate>Sun, 24 Jan 2010 01:00:00 PST</pubDate><link>http://mnt.to/f/3wHD</link><guid>http://mnt.to/f/3wHD</guid><description>If you think heart disease is a disease of the middle aged, think again.  Experts recommend that cholesterol screening should begin as early as 20 years of age because it is a key indicator of heart&#45;attack risk, and should be rechecked at least once every five years.  Atherosclerosis begins early, says Dr...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Research Published By Standard Process Inc. Scientists About The Effects Of Dietary Intervention On Cholesterol Levels</title><pubDate>Tue, 19 Jan 2010 06:00:00 PST</pubDate><link>http://mnt.to/f/3wvG</link><guid>http://mnt.to/f/3wvG</guid><description>In collaboration with the scientists in the Department of Animal Sciences at the University of Wisconsin&#45;Madison, Standard Process scientists have published a study examining the effects of nutritional supplement ingredients on cholesterol levels in Rapacz familial hypercholesterolemic swine or FH swine. Findings of this study were reported in the Journal of Medicinal Food...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Higher Statin Doses Not Always Best At Preventing Coronary Artery Disease</title><pubDate>Tue, 19 Jan 2010 02:00:00 PST</pubDate><link>http://mnt.to/f/3wvj</link><guid>http://mnt.to/f/3wvj</guid><description>Statins have proven highly effective at lowering cholesterol. Typically, a treat&#45;to&#45;target approach, which means treating to a target cholesterol level, is taken with statin therapy. However, some experts believe that a tailored approach that uses different dosages based on pateints' risk for cardiovascular disease may be a better strategy for reducing the risk of coronary artery disease...</description><category domain="http://www.medicalnewstoday.com/sections/statins/">Statins</category></item>
<item><title>Treat The Risk, Not The Cholesterol: Study Challenges Current Cholesterol Recommendations</title><pubDate>Tue, 19 Jan 2010 01:00:00 PST</pubDate><link>http://mnt.to/f/3wv3</link><guid>http://mnt.to/f/3wv3</guid><description>A new study by the University of Michigan Medical School and VA Ann Arbor Health System challenges the medical thinking that the lower the cholesterol, the better...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets</title><pubDate>Mon, 18 Jan 2010 04:00:00 PST</pubDate><link>http://mnt.to/f/3wsP</link><guid>http://mnt.to/f/3wsP</guid><description>Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL&#174; (Colesevelam HCl) tablets, 625 mg.  Impax filed its Abbreviated New Drug Application ("ANDA") containing a paragraph IV certification for a generic version of WELCHOL&#174; with the U.S. Food &#38; Drug Administration ("FDA")...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Despite FDA Warnings, The Monitoring Of High&#45;Risk Medications Remains Unchanged</title><pubDate>Wed, 13 Jan 2010 05:00:00 PST</pubDate><link>http://mnt.to/f/3wg6</link><guid>http://mnt.to/f/3wg6</guid><description>A new study concludes that many doctors appear to have largely ignored a Food and Drug Administration warning to screen users of new antipsychotic drugs for high blood sugar and cholesterol, which poses risks to their health and raises questions about the efficacy of warning protocols in general...</description><category domain="http://www.medicalnewstoday.com/sections/regulatoryaffairs/">Regulatory Affairs / Drug Approvals</category></item>
<item><title>Amarin Corporation Announces First Patients Enrolled In Two Phase 3 Clinical Trials Assessing AMR101 For The Treatment Of Cardiovascular Disease</title><pubDate>Tue, 12 Jan 2010 01:00:00 PST</pubDate><link>http://mnt.to/f/3w9g</link><guid>http://mnt.to/f/3w9g</guid><description>Amarin Corporation plc (Nasdaq: AMRN), a clinical&#45;stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, announced that first patients were enrolled in the MARINE and ANCHOR Phase 3 clinical trials for AMR101, the Company's lead product candidate...</description><category domain="http://www.medicalnewstoday.com/sections/cardiovascular/">Cardiovascular / Cardiology</category></item>
<item><title>Tekmira Pharmaceuticals Completes ApoB SNALP Phase 1 Clinical Trial</title><pubDate>Fri, 08 Jan 2010 03:00:00 PST</pubDate><link>http://mnt.to/f/3w4Y</link><guid>http://mnt.to/f/3w4Y</guid><description> Tekmira Pharmaceuticals Corporation (TSX:TKM) announced that it has concluded its ApoB SNALP Phase 1 human clinical trial. ApoB SNALP is designed to reduce the production of apolipoprotein B (ApoB), a protein produced in the liver that plays a central role in cholesterol metabolism.  Tekmira enrolled a total of 23 subjects in its Phase 1 clinical trial...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Good Cholesterol Not As Protective In People With Type 2 Diabetes</title><pubDate>Wed, 23 Dec 2009 01:00:00 PST</pubDate><link>http://mnt.to/f/3vM6</link><guid>http://mnt.to/f/3vM6</guid><description>High&#45;density lipoprotein (HDL), known as "good" cholesterol, isn't as protective for people with type 2 diabetes, according to research reported in Circulation: Journal of the American Heart Association. HDL carries cholesterol out of the arteries, and high levels are associated with a lower risk of heart disease...</description><category domain="http://www.medicalnewstoday.com/sections/heart-disease/">Heart Disease</category></item>
<item><title>Low CETP Activity Associated With Heart Disease Risk</title><pubDate>Tue, 15 Dec 2009 18:00:00 PST</pubDate><link>http://mnt.to/f/3vxq</link><guid>http://mnt.to/f/3vxq</guid><description>Although seen as a potential heart disease therapy, raising high&#45;density lipoprotein (HDL) cholesterol levels by inhibiting activity of a transfer protein may not be effective, a new study suggests...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Modifiable Risk Factors For Heart Disease Identified By New Research</title><pubDate>Mon, 14 Dec 2009 01:00:00 PST</pubDate><link>http://mnt.to/f/3vrK</link><guid>http://mnt.to/f/3vrK</guid><description>Special issue focuses on cardiovascular disease prevention and outcomes Emerging research on cardiovascular risk factors and treatment effects are helping clinicians gain a better understanding of which patients are most likely to benefit from close monitoring, lifestyle changes and/or additional therapeutic interventions...</description><category domain="http://www.medicalnewstoday.com/sections/heart-disease/">Heart Disease</category></item>
<item><title>Patients With High CRP And Normal LDL Have Long&#45;Term Risk For Heart Disease, Stroke And Death</title><pubDate>Sun, 13 Dec 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3vqg</link><guid>http://mnt.to/f/3vqg</guid><description>New research shows a long&#45;term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long&#45;term risk for heart attack, stroke and death...</description><category domain="http://www.medicalnewstoday.com/sections/heart-disease/">Heart Disease</category></item>
<item><title>Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR&#174; (niacin Extended&#45;release/simvastatin)</title><pubDate>Sat, 12 Dec 2009 01:00:00 PST</pubDate><link>http://mnt.to/f/3vqT</link><guid>http://mnt.to/f/3vqT</guid><description>Abbott has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR&#174;, a cholesterol medication. SIMCOR is a fixed&#45;dose combination of niacin extended&#45;release and simvastatin...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>University Of Texas Southwestern Medical Center Researcher Wins Avanti Award In Lipids</title><pubDate>Sat, 12 Dec 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3vpb</link><guid>http://mnt.to/f/3vpb</guid><description>The 2010 Avanti Award in Lipids, which recognizes outstanding research contributions in the area of lipid research, has been awarded to David W. Russell, the Eugene McDermott distinguished chair of molecular genetics at the University of Texas Southwestern Medical Center at Dallas...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Abbott Seeks FDA Approval Of New Dosage Strengths Of SIMCOR(R) (niacin Extended&#45;release/simvastatin)</title><pubDate>Fri, 11 Dec 2009 04:00:00 PST</pubDate><link>http://mnt.to/f/3vmN</link><guid>http://mnt.to/f/3vmN</guid><description>Abbott (NYSE:  ABT) has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) for two new dosage strengths of SIMCOR&#174;, a cholesterol medication. SIMCOR is a fixed&#45;dose combination of niacin extended&#45;release and simvastatin...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>Fruit Flies Can Shed Light On High Cholesterol, Obesity In Humans</title><pubDate>Thu, 03 Dec 2009 05:00:00 PST</pubDate><link>http://mnt.to/f/3v26</link><guid>http://mnt.to/f/3v26</guid><description>How do fruit flies get high cholesterol and become obese? The same way as people do &#45; by eating a diet that's too rich in fats. More importantly, according to two new studies led by a University of Utah human geneticist, fruit flies use the same molecular mechanisms as humans to help maintain proper balances of cholesterol and a key form of stored fat that contributes to obesity...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>SDI Reports: Prescriptions For Patients New To Niaspan Rise 41% In Week Following Release Of Arbiter 6&#45;HALTS Study Results</title><pubDate>Sun, 29 Nov 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3tMm</link><guid>http://mnt.to/f/3tMm</guid><description>In the week ending Friday, Nov. 20 &#45; after the American Heart Association and New England Journal of Medicine released results of the Arbiter 6&#45;HALTS study on Saturday, Nov. 14 &#45; patients new to Niaspan filled 13,255 prescriptions for the cholesterol therapy, an increase of 41% from the week ending Nov. 13...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
<item><title>First 'Genetic Map' Of Han Chinese May Aid Search For Disease Susceptibility Genes</title><pubDate>Fri, 27 Nov 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3tLT</link><guid>http://mnt.to/f/3tLT</guid><description>The first genetic historical map of the Han Chinese, the largest ethnic population in the world, as they migrated from south to north over evolutionary time was published online by the American Journal of Human Genetics by scientists at the Genome Institute of Singapore (GIS)...</description><category domain="http://www.medicalnewstoday.com/sections/genetics/">Genetics</category></item>
<item><title>Science News From Weill Cornel: November 2009</title><pubDate>Mon, 23 Nov 2009 00:00:00 PST</pubDate><link>http://mnt.to/f/3txM</link><guid>http://mnt.to/f/3txM</guid><description>Dr. Samie Jaffrey Receives Competitive NIH Director's T&#45;R01 Award Speedier Lab Testing With Results That Glow in the Dark Dr. Samie Jaffrey, associate professor of pharmacology at Weill Cornell Medical College, is among the first researchers to win a prestigious NIH Director's Transformative R01 award from the National Institutes of Health. Dr...</description><category domain="http://www.medicalnewstoday.com/sections/parkinsons_disease/">Parkinson's Disease</category></item>
<item><title>COLD&#45;FX(R) Maker Broadens Its Scientific Direction: Launches Pilot Trial Of New Formulation LIP&#45;01 Geared To Lowering Cholesterol And Lipids</title><pubDate>Fri, 20 Nov 2009 02:00:00 PST</pubDate><link>http://mnt.to/f/3tv5</link><guid>http://mnt.to/f/3tv5</guid><description>Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) maker of COLD&#45;FX  announced the launch of a pilot clinical trial of a new formulation, LIP&#45;01 that has shown promise in reducing blood lipids &#45; including cholesterol. Cholesterol can stick to the walls of arteries, causing atherosclerosis or "hardening of the arteries." This, in turn, can ultimately lead to a heart attack or stroke...</description><category domain="http://www.medicalnewstoday.com/sections/cholesterol/">Cholesterol</category></item>
</channel></rss>